Neuropeptide Y (NPY) immunoreactive (-ir) nerve fibers densely innervate hypophysiotropic TRH perikarya and dendrites in the hypothalamic paraventricular nucleus (PVN). To evaluate the contribution of the arcuate nucleus (Arc) to this innervation, the effect of Arc ablation by neonatal monosodium glutamate (MSG) treatment on the density of NPY-fibers contacting TRH neurons in the PVN was investigated. After the lesioned animals and vehicle-treated controls reached adulthood, the number of contacts between NPY-ir boutons and TRH-ir perikarya in the PVN was determined in double-immunostained sections. In controls, numerous contacts between NPY-ir terminals and TRH perikarya and dendrites were observed, confirming earlier findings. MSG treatment resulted in a marked reduction of the size of the Arc and also the number of NPY-perikarya with a concomitant reduction of 82.4 Ϯ 2.1% in the relative number of NPY terminals contacting TRH perikarya and first order dendrites in the medial parvocellular and periventricular subdivisions of the PVN. In contrast, lesioning of the ascending adrenergic bundle in the brain stem caused no statistically significant change in the number of NPYterminals in close apposition to hypophysiotropic TRH neurons in the PVN. These data confirm earlier findings that NPY-containing axon terminals innervate TRH neurons in the PVN and further demonstrate a potentially important anatomical relationship between NPYproducing neurons in the Arc and hypophysiotropic TRH neurons. (Endocrinology 139: [3262][3263][3264][3265][3266][3267][3268][3269][3270] 1998) T RH IS THE principal hypothalamic regulatory factor of anterior pituitary TSH secretion (1). Hypophysiotropic TRH neurons reside in the medial and periventricular parvocellular subdivisions of the hypothalamic paraventricular nucleus (PVN) and control the anterior pituitary thyrotrophs via axonal projections to the external zone of the median eminence (2) where TRH is released into the hypophysialportal blood. The biosynthesis and release of TRH are tightly controlled via negative feedback regulation by thyroid hormone, such that TRH gene expression in the PVN changes inversely to the circulating levels of thyroid hormone. However, under certain conditions such as fasting or sepsis, the set point for feedback regulation on TRH gene expression can be altered (reduced) presumably due to modulation by circulating hormones and/or neural effects intrinsic to the brain (3-6). Hypophysiotropic TRH neurons are readily accessible to neural control by a number of neuroactive substances contained within nerve fibers densely innervating the PVN (for review, see Ref. 1). Among these putative neurotransmitters, neuropeptide Y (NPY) is observed in nerve terminals in all divisions of the PVN (7, 8), which, in particular, innervate hypophysiotropic TRH neurons (9, 10). By electron microscopy, NPY-terminals form both symmetric and asymmetric synapses with TRH-perikarya and dendrites in the parvocellular PVN as well as close membrane appositions without synaptic specializations (9).
T RH IS THE principal hypothalamic regulatory factor of anterior pituitary TSH secretion (1) . Hypophysiotropic TRH neurons reside in the medial and periventricular parvocellular subdivisions of the hypothalamic paraventricular nucleus (PVN) and control the anterior pituitary thyrotrophs via axonal projections to the external zone of the median eminence (2) where TRH is released into the hypophysialportal blood. The biosynthesis and release of TRH are tightly controlled via negative feedback regulation by thyroid hormone, such that TRH gene expression in the PVN changes inversely to the circulating levels of thyroid hormone. However, under certain conditions such as fasting or sepsis, the set point for feedback regulation on TRH gene expression can be altered (reduced) presumably due to modulation by circulating hormones and/or neural effects intrinsic to the brain (3) (4) (5) (6) . Hypophysiotropic TRH neurons are readily accessible to neural control by a number of neuroactive substances contained within nerve fibers densely innervating the PVN (for review, see Ref. 1) . Among these putative neurotransmitters, neuropeptide Y (NPY) is observed in nerve terminals in all divisions of the PVN (7, 8) , which, in particular, innervate hypophysiotropic TRH neurons (9, 10) . By electron microscopy, NPY-terminals form both symmetric and asymmetric synapses with TRH-perikarya and dendrites in the parvocellular PVN as well as close membrane appositions without synaptic specializations (9) .
At least two major sources have been established for NPY innervation of the PVN; a projection from adrenergic/noradrenergic cell groups in from the medulla oblongata where NPY extensively coexists with catecholamines (7) , and a pathway from the hypothalamic arcuate nucleus (Arc) that does not contain catecholamines (11, 12) . To determine the relative contribution of the Arc to the NPY innervation of hypophysiotropic TRH neurons, we investigated the distribution of NPY boutons in juxtaposition with TRH-perikarya and first order dendrites qualitatively and semiquantitatively following ablation of the Arc by neonatal monosodium glutamate (MSG) treatment (13, 14) , and contrasted the results to a separate group of rats with unilateral lesions of the ascending medullary adrenergic pathway (15) . These data have been reported in abstract form (16) .
Materials and Methods

Animal preparation
All procedures involving animals were reviewed and approved by the Animal Research Committee at New England Medical Center and Tufts University School of Medicine.
Monosodium glutamate treatment.
Timed pregnant Sprague-Dawley rats (Taconic Farms, Germantown, NY) were placed in individual plastic cages and, after delivery, male pups were selected for study. Pups received sc injections of 2 mg/g BW of MSG on postnatal days 2 and 4 followed by 4 mg/g BW on days 6, 8, and 10 (12) and were allowed to survive until the age of 2-3 months. Littermates that had been treated with with sc saline injections and normal rats of comparable age at the time of the experiments were used as controls (n ϭ 6). To enhance the detectability of TRH in neuronal cell bodies, axonal transport was blocked in all animals by stereotaxically placed injections of colchicine (75 g/15 l) into the lateral cerebral ventricle (icv) under sodium pentobarbital (Nembutal) anesthesia. Following a survival period of 18 h, the animals were deeply anesthetized, and their brains were perfused via the ascending aorta with saline (30 -50 ml; 30 -60 sec) followed by a mixture of 3.75% acrolein and 2% paraformaldehyde in 0.1 m phosphate buffer (100 -200 ml; 10 -20 min) (17) . After perfusion, the brains were removed, postfixed by immersion in 2% paraformaldehyde for 1-2 h, and stored in 0.01 m PBS, pH 7.4, until prepared for immunohistochemistry.
Lesioning of the ascending adrenergic bundle. Fifteen adult, male SpragueDawley rats (260 -380 g BW) were used for this experiment. The animals were anesthetized, and a unilateral electrolytic lesion was placed into the medulla oblongata under stereotaxic guidance (Ϫ12.0 mm from Bregma anteroposterior; 1.1 mm lateral from midline; 8.1 mm ventral to the skull surface according to the atlas of Paxinos and Watson (18) by passing a DC current (2.5 mA for 2-3 sec) via a monopolar electrode (15) . Following a 14-to 21-day survival period, the animals were administered colchicine icv and perfused for histology as described above.
Single labeling immunohistochemistry
For all animal treatment groups, blocks of the hypothalamus beginning from the anterior part of the PVN to the caudal pole of the arcuate nucleus were sectioned coronally at 30 m thickness on a Vibratome and collected into vials containing PBS. In animals with an electrolytic lesion in the brain stem, 50-m sections were also taken from the medulla oblongata. Sections were treated sequentially with 1% sodium borohydride in 0.05 m phosphate buffer for 30 min and 0.5% hydrogen peroxide in PBS for 15 min. To improve antibody penetration, sections for light microscopy were washed in PBS containing 0.5% Triton X-100 for 1 h. Sections for electron microscopy were rinsed in PBS only. After preincubation in 10% normal horse serum for 1 h, the hypothalamic sections were placed in a rabbit antiserum against NPY (gift of Prof. Julia Polak, Hammersmith Hospital, London, UK) at 1:15,000 -30,000 for light microscopy and at 1:15,000 for electron microscopy. Antiserum was diluted in PBS containing 1% normal horse serum, 0.008% sodium azide and 0.1% Kodak Photo-Flo (Eastman-Kodak, Rochester, NY) and incubated with the tissue sections for 3 days at 4 C under continuous gentle agitation on a rotary shaker. Sections of the brain stem lesion sites and PVN sections from corresponding animals were incubated in a sheep anti-PNMT antiserum (Chemicon, Temecula, CA) at 1:7,500 -10,000. The sections were then washed in PBS (3 ϫ 30 min) and incubated in biotinylated antirabbit or biotinylated antisheep IgG (1:200, Vector Labs) for 3 h at room temperature. After washes in PBS (3 ϫ 10 min), the sections were incubated in avidin-biotin-peroxidase complex (ABC Elite, 1:100, Vector Labs, Burlingame, CA) for 1 h, rinsed in 0.05 m Tris buffer, and immunolabeling was visualized with a mixture of 0.025% diaminobenzidine (DAB) and 0.0036% hydrogen peroxide for 7 min.
Double-immunolabeling for NPY and TRH in the PVN
To visualize neuroanatomical associations of NPY-ir nerve terminals and TRH-ir neurons in the PVN, a double-labeling immunoperoxidase using distinct chromogens for the two peptides was performed. First, NPY-fibers were detected with DAB in PVN sections treated either for light or electron microscopy as described above. This was followed by washes in 0.1 m phosphate buffer, then incubation in the TRH antiserum (at 1:24,000) (19) for 1 day at 4 C, which was developed using benzidine dihydrochloride (BDHC) (20) . BDHC yields a final product distinguishable from DAB both at light and electron microscopic levels due to its green color by light microscopy and its electron dense, crystalline appearance by electron microscopy. Following sequential incubation in biotinylated antirabbit IgG followed by the ABC reagents, the sections were washed in PBS (3 ϫ 10 min) then once in 0.05 m PB (pH 6.5). The sections were preincubated for 1 min in 0.01% BDHC and 0.025% sodium nitroprusside in 0.01 m PB. The reaction mixture was then replaced with a fresh BDHC solution containing 0.0048% hydrogen peroxide in which the sections were further treated for 45 sec. The development was terminated by rinses in 0.05 m PB at pH 6.5. Sections for light microscopy were mounted onto gelatin-coated slides and air-dried overnight then rehydrated in 0.01 m PB (pH 6.5) and lightly osmicated in vertical staining jars with 0.2% osmium tetroxide for 5 min. After rinsing in the same buffer, sections were rapidly dehydrated in an ascending series of ethanol, cleared with three changes of Histosol and coverslipped. Freefloating sections for electron microscopy were treated with 1% osmium tetroxide in 0.05 m PB at pH 6.5 for 30 -45 min at room temperature, then dehydrated in an ascending series of ethanol followed by propylene oxide. Sections were infiltrated with epoxy resin (Durcupan ACM, Fluka, Ronkonkoma, NY) and flat-embedded onto liquid release agent (Electron Microscopy Sciences, Fort Washington, PA)-coated slides, and the resin was polymerized at 56 C for 2 days. Although sections prepared by the light microscopic protocol contained higher numbers of labeled terminals and were suitable for photography, semiquantitative analysis (see below) of contacts between NPY-terminals and TRH neurons was conducted on flat-embedded sections treated for electron microscopy 
Semiquantitative evaluation of contacts between NPY boutons and TRH neurons at light microscopic level
The relative number of close contacts between NPY terminals and TRH perikarya were determined by light microscopic examination in resin-embedded, osmicated, double-immunolabeled sections of the PVN taken at 150-m intervals. Appositions of NPY-ir nerve terminals onto TRH-ir neurons were counted by direct visual examination using a 100ϫ oil immersion lens in the medial parvocellular and periventricular subdivisions of the PVN containing the main cluster of hypophysiotropic TRH neurons (19) (1.8 -2.1 mm caudal to Bregma) and in the parvocellular dorsal cap of the PVN, a site of nonhypophysiotropic parvocellular neurons based on the rat brain atlas of Paxinos and Watson (18) . Close appositions of NPY-terminals were counted on the soma and first order dendrites of at least 100 medial parvocellular and periventricular TRH neurons and 25 TRH neurons in the dorsal cap region from three control and three MSG-treated rats. Values were averaged per animal and compared statistically by ANOVA using StatView (Abacus Concepts, Inc., Surrey, UK).
In the brain stem-lesioned rats, close contacts between NPY boutons and TRH neurons in the PVN were determined as described above, except that the values were compared between the lesioned and unlesioned sides in the same animals.
Electron microscopy
To analyze contacts between NPY-terminals and TRH neurons in the PVN at the ultrastructural level, areas of interest were cut out from the embedded material and glued onto empty resin blocks. Ultrathin sections were prepared with an ultramicrotome (MT 6000, RMC, Inc., Tuscon, AZ) and examined with a Philips CM-10 transmission electron microscope.
Results
Effects of MSG treatment on NPY-ir in the Arc
Examination of cresyl violet stained sections revealed that MSG treatment markedly diminished the size of the Arc due to a severe loss of neuronal cell bodies compared with controls (Fig. 1, A and B) . In NPY-immunolabeled sections from control animals, numerous NPY-ir perikarya were observed throughout the rostrocaudal extent of the Arc and NPY-ir nerve fibers with varicosities were also present in high concentrations (Fig. 1C) . MSG treatment resulted in loss of NPY-ir from nerve fibers and the almost complete disappearance of NPY-labeled cell bodies from the Arc. Only few, lightly immunolabeled NPY-perikarya remained in the atrophied dorsal periventricular region of the Arc (Fig. 1D) .
Effects of MSG treatment on the innervation of PVN by NPY-ir nerve fibers
In control animals, all recognized divisions of the PVN appeared to receive a robust input from nerve fibers containing NPY-ir, but no immunolabeling was observed in neuronal cell bodies. NPY-nerve fibers were seen to enter the PVN in a heavy bundle just lateral to the posterior parvocellular subdivision of the PVN (Fig. 2A) . Beaded nerve fibers, preterminal axonal varicosities, and terminal-like structures formed a particularly dense network in the dorsal part of the medial parvocellular subdivision. The magnocellular division exhibited a comparatively lower density of fibers, although this NPY-innervation was still strikingly more pronounced than that of the surrounding area making the entire PVN stand out of the medial hypothalamus at low power of magnification ( Fig. 2A) . At the caudal one-third of the PVN, the densest accumulation of NPY fibers coincided with the cluster of hypophysiotropic TRH neurons in the dorsal part of the medial parvocellular and periventricular subdivisions (Fig. 3 , A, C, E). At higher magnification, numerous NPYterminals appeared in close contact with TRH-immunolabeled perikarya and dendrites (Fig. 3E) .
Compared with controls, MSG-treated animals exhibited significantly less NPY immunolabeling in nerve fibers throughout the PVN (Fig. 2B , compare with Fig. 2A) . Nevertheless, remaining fibers were still readily detectable in all compartments of the PVN. Occasionally, faintly labeled NPY-ir cell bodies (1-2 cells per section) appeared in MSG treated animals at the ventral or lateral margin of the magnocellular division (data not shown). Double-immunolabeling revealed that the density of NPY-ir terminals surrounding TRH-positive perikarya in the caudal part of the medial parvocellular subdivision was greatly reduced (Fig. 3, B, D, F) . Some residual NPY-ir nerve fibers in MSG-lesioned animals were still observed in close apposition to non-TRH-immunoreactive parvocellular perikarya (Fig. 3, D and F ).
At the electron microscopic level, TRH-labeled perikarya in the medial parvocellular subdivision of the PVN of normal animals were commonly surrounded by several NPYterminals, often with synaptic contacts (Fig. 4A) . Large TRHdendrites were also frequently contacted by NPY-axon terminals (Fig. 4B) . By contrast, in MSG-lesioned rats, NPY boutons were either not found in close contact with TRH neurons (Fig. 5A ), or only rare examples of single immunoreactive NPY-containing boutons were seen in close association with TRH perikarya and proximal dendrites ( Fig. 5B) . NPY contacts persisted, however, with unlabeled neuronal (mostly dendritic) profiles in the PVN (Fig. 5B) .
Quantitative assessment of contacts between NPY-ir boutons and TRH-ir perikarya in the PVN in control and MSGlesioned rats
In the medial parvocellular and periventricular subdivisions of the PVN, the number of close contacts between NPY-fibers and TRH perikarya and first-order dendrites was dramatically reduced in MSG-treated animals by 82.4 Ϯ 2.1% compared with the controls (Table 1) . Numbers of NPY boutons in contact with TRH neurons in the parvocellular dorsal cap of the PVN, which do not have hypophysiotropic function (1, 2) were also reduced by MSG treatment, but less severely, corresponding to a 32% reduction compared with controls ( Table 1) .
Effects of the ascending medullary adrenergic bundle lesion on NPY-ir fibers in the PVN
The effectiveness of ablation of the ascending medullary adrenergic bundle was judged by two criteria identified by immunolabeling for the biosynthetic enzyme of adrenaline, phenylethanolamine-N-methyl transferase (PNMT); the interruption of PNMT-immunopositive fibers in the medulla oblongata within the ascending adrenergic bundle situated ventromedial to the C2 adrenergic cell group, and by the marked reduction in the density of PNMT-ir fibers on the lesioned side of the PVN compared with the intact side (Fig.  6, A and B) . Three rats satisfying these criteria were selected for quantitative analysis of the association between NPYfibers and TRH neurons in the PVN.
As opposed to the marked reduction in the density of PNMT-fibers (Fig. 6B) , medullary lesions caused only small changes in the distribution and density of NPY-ir fibers in the medial parvocellular subdivision and dorsal cap region of the PVN (Fig. 6C) . Quantitative assessment of close contacts between NPY-ir boutons and TRH-ir neurons of the PVN is shown in Table 1 . No significant reduction in NPY contacts on TRH neurons was observed in the medial parvocellular and periventricular subdivisions of the PVN ipsilateral to the lesion compared with the unlesioned side. In contrast, a statistically significant reduction of 14.7% in the number of NPY-terminals contacting TRH neurons was recorded for the parvocellular dorsal cap. Nt 4 ) , identified by the presence of the amorphous DAB reaction product, are in close contact with a TRH perikaryon. TRH immunoreactivity is recognized by the occurrence of the highly electron dense, crystalline benzidine reaction, which is scattered in the cytoplasm (arrowheads). Insets demonstrate synaptic contacts (arrows). B, An example of a large dendritic profile with TRH immunoreactivity closely contacted by several NPY-labeled terminals. Scale bars, 2 m in (A) and (B), 1 m in inset.
Discussion
By residing in the PVN, TRH-producing neurons are situated in an area where they can receive rich afferent inputs from several different regions of the brain, including the hypothalamus, brain stem, and limbic system (1). Previous studies from our laboratory and by other research groups on the morphology and neurotransmitter/peptide content of axons terminating on or near TRH neurons in the PVN have demonstrated that adrenaline/noradrenaline-synthesizing terminals and NPY-fibers comprise the most conspicuous innervation to hypophysiotropic TRH neurons (9, 10, 21, 22) . As the majority of catecholamine-producing neurons in the medulla labeled retrogradely after the stereotaxic implantation of true blue into the PVN also contain NPY (7), we had initially assumed that NPY innervation to TRH neurons in the PVN arises primarily from the brain stem and hypothesized that NPY might have its action on TRH neurons by modulating facilitatory noradrenergic influences (9) . In contrast to the catecholaminergic terminals innervating TRH neurons in the PVN, which establish predominantly asymmetric contacts with cell bodies and dendrites (21, 22) , the NPY input establishes predominantly symmetric specializations, although asymmetric contacts are also seen (9) . These observations raised the possibility that the origin of NPY innervation of hypophysiotropic TRH neurons in the PVN may be heterogeneous, arising partly in the brain stem but also other regions of the brain. In addition, since electrolytic or chemical ablation of the Arc causes a more pronounced loss of immunoreactive NPY fibers from the PVN in general than what is observed after brain stem hemisections (23) , the hypothalamic arcuate nucleus was considered a likely candidate for the origin of the NPY innervation to hypophysiotropic TRH.
To determine the specific contribution of NPY neurons in the Arc to the innervation of hypophysiotropic TRH neurons, we performed double-immunolabeling studies of the PVN at the light and electron microscopic levels following chemical ablation of the Arc with monosodium glutamate. In keeping with the observations by Kerkerian and Pelletier (12) , obliteration of nearly all NPY neurons in the arcuate nucleus by neonatal administration of monosodium glutamate resulted in a partial depletion of NPY-containing fibers in the PVN. The NPY innervation to TRH neurons in the medial parvocellular subdivision of the PVN, however, was substantially depleted, estimated at 82% of normal control animals. NPYcontaining boutons were lost on both TRH perikarya and first order dendrites, indicating that the arcuate nucleus represents the predominant source for the NPY-ergic innervation of hypophysiotropic TRH neurons. In contrast, no significant depletion of NPY-contacts on hypophysiotropic neurons was observed following medullary lesions that dramatically decreased the adrenergic innervation to the PVN. This suggests that the adrenergic innervation of hypophysiotropic TRH perikarya and their proximal dendrites cocontains little if any NPY. Residual NPY boutons in contact with TRH perikarya in the medial parvocellular PVN, therefore, may arise from the small number of remaining NPY neurons in the lesioned arcuate nucleus or other loci in the CNS. One region of potential interest is the hypothalamic dorsomedial nucleus as this nucleus heavily projects to the parvocellular PVN (24) and has been recently shown in the genetically obese agouti mouse to contain a substantial population of NPY messenger RNA (mRNA) containing neurons (25) . Another minor projection from NPY-containing neurons of the intergeniculate leaflet may also exist (26) , which might reach the periventricular area of the PVN via the geniculohypothalamic tract (27) .
Nevertheless, ablation of the medullary catecholamine pathway to the PVN did result in a 14.7% reduction in the number of NPY boutons contacting TRH neurons in the parvocellular dorsal cap region, a subdivision of the PVN that is not believed to have a hypophysiotropic role (1, 2) . Rather, this region may be involved with regulation of the autonomic nervous system by way of descending projections to the lower brain stem (28) . In addition, ablation of NPY neurons in the Arc only partially depleted the PVN of NPYcontaining fibers and ultrastructurally, synaptic contacts of remaining NPY-containing boutons were seen in contact with perikarya and dendrites not labeled with the TRH antiserum. The possibility that NPY afferents to the PVN derive from multiple sources in the brain to target specific cell populations, therefore, seems likely and may provide a way that a single peptide can exert diverse actions in a discrete region of the brain. Even within the Arc itself, NPY neurons may be functionally heterogeneous as there is now anatomical evidence for a population of NPY neurons that also contains the inhibitory neurotransmitter ␥-aminobutyric acid (GABA) in the dorsomedial part of the Arc, whereas a subset of non-GABAergic NPY cells exists in the ventral Arc (29) . The functional significance of the target-specific innervation of TRH neurons by NPY-fibers from the arcuate nucleus may be seen in the potential role of Arc-derived NPY to reset the hypothalamic-pituitary-thyroid axis under certain physiological conditions (3) (4) (5) (6) . Starvation, for example, results in substantial reductions in circulating thyroid hormone levels but is accompanied by a paradoxic reduction in proTRH mRNA in hypophysiotropic neurons in the PVN and inappropriately normal or low circulating TSH levels (3, 4) . These changes occur simultaneously with a marked increase in NPY gene expression in the arcuate nucleus and concomitant increase in NPY release in the PVN (30 -32) . The up-regulation of NPY in the arcuato-paraventricular neural pathway has been implicated in the potent central stimulatory action of NPY on food intake (32, 33) . Moreover, rats with streptozotocin-induced diabetes show similar alterations in the hypothalamic-pituitary-thyroid axis as starved rats (34, 35) and also have an increased NPY content in the Arc and the PVN (36, 37) . Conversely, recent studies from our laboratory have demonstrated that the administration of leptin, a fat cell-derived hormone with anorectic activity that reduces the biosynthesis of NPY in the Arc (38) , prevents the fall in circulating thyroid hormone levels and the reduction of pro-TRH mRNA in the PVN (6) . Because NPY may be inhibitory to the thyroid axis (39), circumstantial evidence is provided to suggest that NPY derived from the arcuate nucleus may modulate the setpoint for feedback regulation on hypophysiotropic TRH neurons in the PVN during starvation by lowering the threshold of these neurons to feedback inhibition by circulating levels of thyroid hormone. Mice with deletion of the NPY gene, however, still have a fall in T4 levels during fasting (40) , suggesting that other mechanisms in addition to NPY may also be operable or that alternative neuronal pathways were induced during development of the CNS that may not be normally present.
In summary, the present study demonstrates that the majority of NPY fibers innervating hypophysiotropic TRH neurons originate from the arcuate nucleus. This finding provides a neuroanatomical basis to hypothesize that the NPYergic arcuato-paraventricular pathway may contribute to the resetting of the hypothalamic-pituitary-thyroid axis during fasting.
